Palisade Capital Management’s AtriCure ATRC Stock Holding History

Palisade Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-150,666	Closed	-$2.54M	–	535
2016 Q1	$2.54M	Sell	150,666 -76,068	-34%	-$1.34M	0.08%	319
2015 Q4	$5.09M	Sell	226,734 -91,830	-29%	-$1.89M	0.17%	204
2015 Q3	$6.98M	Sell	318,564 -236,678	-43%	-$5.91M	0.21%	179
2015 Q2	$13.7M	Sell	555,242 -14,090	-2%	-$315K	0.35%	91
2015 Q1	$11.7M	Buy	569,332 +13,664	+2%	+$265K	0.29%	119
2014 Q4	$11.1M	Buy	555,668 +17,923	+3%	+$308K	0.27%	137
2014 Q3	$7.92M	Sell	537,745 -24,113	-4%	-$384K	0.2%	204
2014 Q2	$10.3M	Buy	561,858 +10,363	+2%	+$172K	0.25%	167
2014 Q1	$10.4M	Buy	+551,495	New	+$11.3M	0.25%	157

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Palisade Capital Management's ATRC Position: Q2 2016 in Review

Palisade Capital Management sold out of AtriCure (ATRC) in Q2 2016, closing a stake of 150,666 shares — an estimated $2.54M sold.

Palisade Capital Management first reported a position in ATRC in Q1 2014 and held it in 9 quarters. The position peaked at $13.7M in Q2 2015. 102 funds tracked by Wall St. Rank hold ATRC as of Q2 2016.

Palisade Capital Management reported no remaining AtriCure position as of Q2 2016 after selling out during the quarter.
Palisade Capital Management sold 150,666 AtriCure shares in Q2 2016, an estimated $2.54M.
Palisade Capital Management first reported a position in AtriCure in Q1 2014 and held it in 9 quarters.
Palisade Capital Management's AtriCure position peaked at $13.7M in Q2 2015.
102 funds tracked by Wall St. Rank held AtriCure as of Q2 2016.

Based on Palisade Capital Management's 13F filing for Q2 2016, filed 2 Aug 2016.